Maiko Katadae
Private Equity Investor at The University of Tokyo Edge Capital Co. Ltd.
Profile
Maiko Katadae is currently a Partner at The University of Tokyo Edge Capital Co. Ltd.
She previously worked as a Director at Elixirgen Therapeutics, Inc.
Maiko Katadae active positions
| Companies | Position | Start |
|---|---|---|
The University of Tokyo Edge Capital Co. Ltd.
 The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | Private Equity Investor | 2010-07-28 |
Former positions of Maiko Katadae
| Companies | Position | End |
|---|---|---|
Elixirgen Therapeutics, Inc.
 Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | Finance |
Elixirgen Therapeutics, Inc.
Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD. | Health Technology |
- Stock Market
- Insiders
- Maiko Katadae
